MR imaging of musculoskeletal tumors and tumor mimickers with intravenous gadolinium: Experience with 242 patients

Skeletal Radiology

Volumn 26, Issue 1, 1997, Pages 2-15

  May, David A ^a   Good, Robert B ^a   Smith, Douglas K ^a,b   Parsons, Theodore W ^a  

^a WILFORD HALL MEDICAL CENTER   (United States)

^b PRESBYTERIAN HOSPITAL   (United States)

Author keywords

Gadolinium; Ganglion cyst; Magnetic resonance imaging; Morton's neuroma; Myxoma; Sarcoma; Tumor

Indexed keywords

GADOLINIUM; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE; GADOTERIDOL;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE TUMOR; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MYXOMA; NEUROMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SYNOVITIS; TUMOR BIOPSY;

ADOLESCENT; ADULT; AGED; BONE NEOPLASMS; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; DRUG COMBINATIONS; FEMALE; FOLLOW-UP STUDIES; GADOLINIUM; GADOLINIUM DTPA; HETEROCYCLIC COMPOUNDS; HUMANS; INFUSIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MIDDLE AGED; MUSCLE NEOPLASMS; NEOPLASMS, CONNECTIVE TISSUE; ORGANOMETALLIC COMPOUNDS; PENTETIC ACID; SENSITIVITY AND SPECIFICITY;

EID: 0031035158     PISSN: 03642348     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002560050183     Document Type: Article

References (44)

1. Crim JR, Seeger LL, Yao L, Chandnani V, Eckardt JJ. Diagnosis of soft-tissue masses with MR imaging: can benign masses be differentiated from malignant ones? Radiology 1992; 185:581-586.
2. de Baere T, Vanel D, Shapeero LG, Charpentier A, Terrier P, di Paola M. Osteosarcoma after chemotherapy: evaluation with contrast material-enhanced subtraction MR imaging. Radiology 1992; 185:587-592.
3. Golfieri R, Baddeley H, Pringle JS, Leung AW, Greco A, Souhami R, et al. Primary bone tumors: MR morphologic appearance correlated with pathologic examinations. Acta Radiol 1991; 32:290-298.
4. Pettersson H, Gillespy TD, Hamlin DJ, Enneking WF, Springfield DS, Andrew ER, et al. Primary musculoskeletal tumors: examination with MR imaging compared with conventional modalities. Radiology 1987; 164:237-241.
5. Sundaram M, McGuire MH, Herbold DR. Magnetic resonance imaging of soft tissue masses: an evaluation of fifty-three histologically proven tumors. Magn Reson Imaging 1988; 6:237-248.
6. Berquist TH. Magnetic resonance imaging of primary skeletal neoplasms. Radiol Clin North Am 1993; 31:411-424.
7. Smith DK, Wright J. Water bags: an inexpensive method for improving fat suppression in MR imaging of the extremities (letter). AJR 1994; 162:1252-1253.
8. Reiser M, Bohndorf K, Niendorf HP, Friedmann G, Erlemann R, Kunze V. Initial experiences with gadolinium DTPA in magnetic resonance tomography of bone and soft tissue tumors (in German). Radiologe 1987; 27:467-472.
9. Schima W, Amann G, Stilbauer R, Windhager R, Kramer J, Nicolakis M, et al. Preoperative staging of osteosarcoma: efficacy of MR imaging in detecting joint involvement. AJR 1994; 163:1171-1175.
10. De Schepper AM, Ramon FA, Degryse HR. Magnetic resonance imaging of soft tissue tumors. J Belge Radiol 1992; 75:286-296.
11. Erlemann R, Reiser MF, Peters PE, Vasallo P, Nommensen B, Kusnierz-Glaz CR, et al. Musculoskeletal neoplasms: static and dynamic Gd-DTPA-enhanced MR imaging. Radiology 1989; 171:767-773.
12. Geirnaerdt MJ, Bloem JL, Eulderink F, Hogendoorn PC, Taminiau AH. Cartilaginous tumors: correlation of gadolinium-enhanced MR imaging and histopathologic findings. Radiology 1993; 186:813-817.
13. Herrlin K, Ling LB, Pettersson H, Willen H, Rydholm A, Gadolinium-DTPA enhancement of soft tissue tumors in magnetic resonance imaging. Acta Radiol 1990; 31:233-236.
14. Pettersson H, Ackerman N, Kaude J, Googe RE, Mancuso AA, Scott KN, et al. Gadolinium-DTPA enhancement of experimental soft tissue carcinoma and hemorrhage in magnetic resonance imaging. Acta Radiol 1987; 28:75-78.
15. Pettersson H, Eliasson J, Egund N, Rooser B, Willen H, Rydholm A, et al. Gadolinium-DTPA enhancement of soft tissue tumors in magnetic resonance imaging: preliminary clinical experience in five patients. Skeletal Radiol 1988; 17:319-323.
16. Pettersson H, Hamlin DJ, Scott KN. Magnetic resonance imaging of primary musculoskeletal tumors. Crit Rev Diagn Imaging 1986; 26:241-263.
17. Erickson SJ, Canale PB, Carrera GF, Johnson JE, Shereff MJ, Gould JS, et al. Interdigital (Morton) neuroma: high-resolution MR imaging with a solenoid coil. Radiology 1991; 181:833-836.
18. Terk M, Kwong P, Suthar M, Horvath B, Colletti P. Morton neuroma: evaluation with MR imaging performed with contrast enhancement and fat suppression. Radiology 1993; 189:239-241.
19. Unger H, Mattoso P, Drusen M, Neumann C. Gadopentate-enhanced magnetic resonance imaging with fat suppression in the evaluation of Morton's neuroma of the foot. J Foot Surg 1992; 31:244-246.
20. Kransdorf M. Question and answer. AJR 1995; 165:1545
21. Seeger LL, Widoff BE, Bassett LW, Rosen G, Eckardt JJ. Preoperative evaluation of osteosarcoma: value of gadopentetate dimeglumine-enhanced MR imaging. AJR 1991; 157:347-351.
22. Harkens KL, Moore TE, Yuh WT, Kathol MH, Hawes DR, el-Khoury GY, et al. Gadolinium-enhanced MRI of soft tissue masses. Australas Radiol 1993; 37:30-34.
23. Erlemann R, Vassallo P, Bongartz G, Muller-Miny H, Rummeny E, Stober U, et al. Musculoskeletal neoplasms: fast low-angle shot MR imaging with and without Gd-DTPA. Radiology 1990; 176:489-495.
24. Hanna SL, Fletcher BD, Parham DM, Bugg MF. Muscle edema in musculo-skeletal tumors: MR imaging characteristics and clinical significance. J Magn Reson Imaging 1991; 1:441-449.
25. Erlemann R. Dynamic, gadolinium-enhanced MR imaging to monitor tumor response to chemotherapy. Radiology 1993; 186:904-905.
26. Fletcher BD, Hanna SL. Musculoskeletal neoplasms: dynamic Gd-DTPA-enhanced MR imaging (letter). Radiology 1990; 177:287-288.
27. Ozaki T, Inoue H, Taguchi K, Sugihara S. Gadolinium-DTPA enhanced magnetic resonance imaging of bone and soft tissue sarcomas in comparison with pathological findings. Acta Med Okayama 1992; 46:471-477.
28. Beltran J, Simon DC, Katz W, Weis LD. Increased MR signal intensity in skeletal muscle adjacent to malignant tumors: pathologic correlation and clinical relevance. Radiology 1987; 162:251-255.
29. Fletcher BD, Hanna SL, Fairclough DL, Gronemeyer SA. Pediatric musculoskeletal tumors: use of dynamic, contrast-enhanced MR imaging to monitor response to chemotherapy. Radiology 1992; 184:243-248.
30. Aoki J, Sone S, Fujioka F, Terayama K, Ishii K, Karakida O, et al. MR of enchondroma and chondrosarcoma: rings and arcs of Gd-DTPA enhancement. J Comput Assist Tomogr 1991; 15:1011-1016.
31. Prayer L, Imhof H, Stiglbauer R, Kramer J, Wimberger D. Gadolinium-DTPA in magnetic resonance tomography: clinical use-indications (in German). Rontgenblatter 1989; 42:493-498.
32. Rosenthal RE, Wozney P. Diagnostic value of gadopentetate dimeglumine for 1.5-T MR imaging of musculoskeletal masses: comparison with unenhanced T1-and T2-weighted imaging. J Magn Reson Imaging 1991; 1:547-551.
33. Berquist TH. Magnetic resonance imaging of the foot and ankle (review). Semin Ultrasound CT MR 1990; 11:327-345.
34. Hanna SL, Parham DM, Fairclough DL, Meyer WH, Le AH, Fletcher BD. Assessment of osteosarcoma response to preoperative chemotherapy using dynamic FLASH gadolinium-DTPA-enhanced magnetic resonance mapping. Invest Radiol 1992; 27:367-373.
35. Bonnerot V, Charpentier A, Frouin F, Kalifa C, Vanel D, Di Paola R. Factor analysis of dynamic magnetic resonance imaging in predicting the response of osteosarcoma to chemotherapy. Invest Radiol 1992; 27:847-855.
36. Crim JR, Seeger LL. Diagnosis of low grade chondrosarcoma (editorial). Radiology 1993; 189:503-504.
37. Simon MA. Biopsy of musculoskeletal tumors. J Bone Joint Surg Am 1982; 64A:1253-1257.
38. McDonald D. Limb-salvage surgery for treatment of sarcomas of the extremities. AJR 1994; 163:509-513.
39. Vanel D, Shapeero LG, De Baere T, et al. MR imaging in the follow-up of malignant and aggressive soft tissue tumors: results of 511 examinations. Radiology 1994; 190:263-268.
40. Peterson KK, Renfrew DL, Feddersen RM, Buckwalter JA, el-Khoury GY. Magnetic resonance imaging of myxoid containing tumors. Skeletal Radiol 1991; 20:245-250.
41. Choi BI, Lee DH, Han MC. Necrotic areas in VX2 carcinoma of rabbits. Correlation of magnetic resonance imaging and pathologic appearance. Invest Radiol 1993; 28:33-38.
42. Sundaram M. Radiographic and magnetic resonance imaging of bone and soft-tissue tumors and myeloproliferative disorders. Curr Opin Radiol 1991; 3:746-751.
43. Lang P, Honda G, Roberts V, et al. Musculoskeletal neoplasm: perineoplastic edema versus tumor on postcontrast MR images with spatial mapping of instantaneous enhancement rates. Radiology 1995; 197:831-839.
44. Morrison WB, Schweitzer ME, Bock GW, et al. Diagnosis of osteomyelitis: utility of fat-suppressed contrast enhanced MR imaging. Radiology 1993; 189:251-257.